In the cohort of young patients with LUAD from our center, we observed obvious heterogeneity between our cohort and the population of lung cancer worldwide [4]; 73.24% of our young patients harbored EGFR or ALK mutations. The gene discussed is EGFR; the disease is lung cancer.